Pay in 4 interest-free payments of $5.20 Learn more
Ships within 48 hours · Estimated delivery Aug 21 - Aug 26
PMID 39381848
In a recent double-blind, randomized, placebo-controlled trial, the effect of ALCAR was examined in 229 participants treated for type 2 diabetes mellitus, hypertension, and dyslipidemia (46)
[1] It was first used to treat diabetes in 1957, however, it received limited attention since it was less potent than other medications
Sent to Or tap the link in your email
In pancreatic cancer, LAT2 ( SLC7A8 ) was shown to decrease gemcitabine sensitivity by regulating glutamine-dependent mTOR activation to promote proliferation and inhibit apoptosis (Feng et al., 2018)
US$ 29.24
US$ 29.01
US$ 29.43
US$ 27.98
US$ 22.72
US$ 28.65
US$ 24.47
